Radicava (edaravone)

pCPA File Number: 22138
Negotiation Status:
Concluded with an LOI
Indication(s):
Amyotrophic Lateral Sclerosis (ALS)
Sponsor/Manufacturer:
Mitsubishi Tanabe Pharma Canada, Inc.
CDA-AMC Project Number:
SR0727-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: